In this free webinar, learn how pregnancy exposure registries are helping in assessing medication safety and thus enhance pregnancy safety studies. Attendees will learn about the historical context of ...
OrigAMI-1 is the first study to show amivantamab plus chemotherapy may provide clinically meaningful benefits to patients with metastatic colorectal cancer who have not received any EGFR-targeted ...
Tactics used to persuade U.S. doctors that potent painkillers could be safely prescribed have been used abroad, an ...
Trimble opened its 2024 Insight Tech Conference with leaders Rob Painter, president and CEO, and Michael Kornhauser, sector vice president, transportation and logistics, discussing the rapid ...
The European Medicines Agency also said that extra doses of the Moderna and Pfizer-BioNTech vaccines could be given to people with underlying health conditions as early as 28 days after a second dose.
The World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list. The prequalification approval is expected to facilitate ...
The European Medicines Agency has revealed a list of five cities that are preferred as its new location by staff after Brexit, following warnings of a public health disaster if EU leaders pick the ...
A survey by Cultural Affairs Agency shows that a record high two out of three people in Japan don't read books. The agency queried 6,000 people aged 16 or over, from January to March, about their ...
With heatwaves pummeling countries across Europe this summer, it is not surprising many people have chosen to vacation in the cooler months. Searches for winter holidays have been soaring and an ...
Brotherless Night by V.V. Ganeshananthan wins the Women’s Prize for Fiction 2024 By Ankhi Mukherjee Professor of English and ...
The German government under Angela Merkel welcomed more than one million new arrivals during the migrant crisis of 2015-2016 but is now following other European countries in toughening up rules as ...